Arizona Bioscience News: TGen receives $1M for cancer trial; UA science student to Capitol Hill; ASU Biodesign canine cancer study

March 15, 2018

By brianpowell

UA research travels to Capitol Hill / Daily Wildcat

Lindsey Chew, a University of Arizona neuroscience and cognitive science senior and Flinn Scholar whose research has focused on creating non-opioid related pain treatments, will represent Arizona at the 22nd annual Posters on the Hill in Washington D.C., which aims to connect politicians with undergraduate scientific researchers and their work.

ASU Biodesign Institute unveils cancer study on canines
/ State Press

A vaccine created at the Arizona State University Biodesign Institute that could potentially prevent all cancers in canines will be tested thanks to a $6.4 million grant.

Ed Zito to retire after 15 years as president of Alliance Bank / Phoenix Business Journal

Ed Zito, a longtime member of Arizona’s Bioscience Roadmap Steering Committee and leader in the state’s commercial banking and public finance sectors, will retire later this month from Alliance Bank of Arizona.

Destroy Pancreatic Cancer gives $1 million to TGen / AZ Big Media

Destroy Pancreatic Cancer, an Atlanta-based nonprofit, is donating $1 million for a unique pancreatic cancer clinical trial designed by Translational Genomics Research Institute’s Dr. Daniel Von Hoff.

UA highlighting Brain Awareness Week with free talk / Arizona Public Media

It is international Brain Awareness Week, and the University of Arizona College of Medicine is showcasing some of its research into this mysterious organ.

Arizona Science Center committed to education transformation / Phoenix Business Journal (Op-ed)

Chevy Humphrey, the president and CEO of Arizona Science Center, writes about the center’s efforts to support both students and teachers while delivering STEM curriculum and educational opportunities outside the classroom.